165 related articles for article (PubMed ID: 38182638)
21. Identification of prognostic biomarkers among ICAMs in the breast cancer microenvironment.
Chen H; Pu S; Mei N; Liu X; He J; Zhang H
Cancer Biomark; 2022; 35(4):379-393. PubMed ID: 36373309
[TBL] [Abstract][Full Text] [Related]
22. Integrative Analysis of the Expression of SIGLEC Family Members in Lung Adenocarcinoma via Data Mining.
Zhang H; Xie Y; Hu Z; Yu H; Xie X; Ye Y; Xu W; Nian S; Yuan Q
Front Oncol; 2021; 11():608113. PubMed ID: 33796453
[No Abstract] [Full Text] [Related]
23. Siglec-15 Regulates the Inflammatory Response and Polarization of Tumor-Associated Macrophages in Pancreatic Cancer by Inhibiting the cGAS-STING Signaling Pathway.
Li H; Zhu R; Liu X; Zhao K; Hong D
Oxid Med Cell Longev; 2022; 2022():3341038. PubMed ID: 36105484
[TBL] [Abstract][Full Text] [Related]
24. Discovery and expression of 3 siglecs-like in Oreochromis niloticus neutrophil, and their interaction with group B streptococcal sialylated capsular polysaccharides.
Dong J; Wei Y; Ye X; Sun C; Tian Y; Lu M; Du J; Chen Z
Mol Immunol; 2016 May; 73():158-69. PubMed ID: 26847490
[TBL] [Abstract][Full Text] [Related]
25. Siglec-9
Wang Y; He M; Zhang C; Cao K; Zhang G; Yang M; Huang Y; Jiang W; Liu H
J Immunother Cancer; 2023 Sep; 11(9):. PubMed ID: 37709296
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of p16, p53, and pcna in sarcoma and an evaluation of immune infiltration.
Cai D; Ma X; Guo H; Zhang H; Bian A; Yu H; Cheng W
J Orthop Surg Res; 2022 Jun; 17(1):305. PubMed ID: 35689249
[TBL] [Abstract][Full Text] [Related]
27. Immune-related prognostic genes signatures in the tumor microenvironment of sarcoma.
Wang J; Gong M; Xiong Z; Zhao Y; Xing D
Math Biosci Eng; 2021 Mar; 18(3):2243-2257. PubMed ID: 33892543
[TBL] [Abstract][Full Text] [Related]
28. Association of NCAP family genes with prognosis and immune infiltration of human sarcoma.
Jiang G; Tian Q; Shi P; Li Z; Li Y; Chen J; Wang W; Chen R; Zhong H; Wu G
Aging (Albany NY); 2023 May; 15(10):4108-4121. PubMed ID: 37192046
[TBL] [Abstract][Full Text] [Related]
29. Siglec-5 is an inhibitory immune checkpoint molecule for human T cells.
Vuchkovska A; Glanville DG; Scurti GM; Nishimura MI; White P; Ulijasz AT; Iwashima M
Immunology; 2022 Jun; 166(2):238-248. PubMed ID: 35290663
[TBL] [Abstract][Full Text] [Related]
30. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
Front Immunol; 2019; 10():6. PubMed ID: 30761122
[No Abstract] [Full Text] [Related]
31. Siglec and anti-Siglec therapies.
Murugesan G; Weigle B; Crocker PR
Curr Opin Chem Biol; 2021 Jun; 62():34-42. PubMed ID: 33607404
[TBL] [Abstract][Full Text] [Related]
32. Comprehensive analysis of immune implication and prognostic value of DHX33 in sarcoma.
Zhang X; Shao Y; Zhou Y; Zhu Z; Wang X
Medicine (Baltimore); 2023 Apr; 102(17):e33654. PubMed ID: 37115050
[TBL] [Abstract][Full Text] [Related]
33. MJDs family members: Potential prognostic targets and immune-associated biomarkers in hepatocellular carcinoma.
Zhou L; Chen G; Liu T; Liu X; Yang C; Jiang J
Front Genet; 2022; 13():965805. PubMed ID: 36159990
[TBL] [Abstract][Full Text] [Related]
34. Sialoglycans and Siglecs Can Shape the Tumor Immune Microenvironment.
van de Wall S; Santegoets KCM; van Houtum EJH; Büll C; Adema GJ
Trends Immunol; 2020 Apr; 41(4):274-285. PubMed ID: 32139317
[TBL] [Abstract][Full Text] [Related]
35. Down-regulation of siglec-2 (CD22) predicts worse overall survival from HBV-related early-stage hepatocellular carcinoma: a preliminary analysis from Gene Expression Omnibus.
Ren X; Ji Y; Jiang X; Qi X
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30355653
[TBL] [Abstract][Full Text] [Related]
36. Self-associated molecular patterns mediate cancer immune evasion by engaging Siglecs on T cells.
Stanczak MA; Siddiqui SS; Trefny MP; Thommen DS; Boligan KF; von Gunten S; Tzankov A; Tietze L; Lardinois D; Heinzelmann-Schwarz V; von Bergwelt-Baildon M; Zhang W; Lenz HJ; Han Y; Amos CI; Syedbasha M; Egli A; Stenner F; Speiser DE; Varki A; Zippelius A; Läubli H
J Clin Invest; 2018 Nov; 128(11):4912-4923. PubMed ID: 30130255
[TBL] [Abstract][Full Text] [Related]
37. Enhancement of Siglec-8 expression predicts adverse prognosis in patients with clear cell renal cell carcinoma.
Ou C; Liu L; Wang J; Dai S; Qu Y; Xiong Y; Xi W; Xu J; Guo J
Urol Oncol; 2017 Oct; 35(10):607.e1-607.e8. PubMed ID: 28619634
[TBL] [Abstract][Full Text] [Related]
38. Identification of the GTPase IMAP family as an immune-related prognostic biomarker in the breast cancer tumor microenvironment.
Huo X; Shen G; Li J; Wang M; Xie Q; Zhao F; Ren D; Dong Q; Zhao J
Gene; 2022 Feb; 812():146094. PubMed ID: 34896519
[TBL] [Abstract][Full Text] [Related]
39. System analysis of
Situ Y; Gao R; Lei L; Deng L; Xu Q; Shao Z
Int J Biol Markers; 2022 Jun; 37(2):158-169. PubMed ID: 35254116
[TBL] [Abstract][Full Text] [Related]
40. Leishmania donovani Utilize Sialic Acids for Binding and Phagocytosis in the Macrophages through Selective Utilization of Siglecs and Impair the Innate Immune Arm.
Roy S; Mandal C
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004904. PubMed ID: 27494323
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
